http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DD-293050-A5
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3be2429bd1a83fd492acffa31808839c |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-175 |
| filingDate | 1989-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4d9e22affd9ca4afa2ae95091eefbcf7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_986f0f60a49155676769e360892dd22c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e33e1b76037f9e5b592cda2de5188dfc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_22479bc95a3d5fbd851b7dc8c89f946f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea6f93702dffd6ff0f7b7f153e4bcc54 |
| publicationDate | 1991-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | DD-293050-A5 |
| titleOfInvention | METHOD FOR THE PRODUCTION OF A MEDIUM AGAINST RETROVIRAL DISEASES |
| abstract | The invention relates to a method for producing an agent against retroviral diseases, which ensures a high bioavailability. Field of application is the pharmaceutical industry. According to the invention, ambazon is processed in the form of soluble salts with pharmaceutical excipients and adjuvants and is prepared therefrom into injection and infusion solutions, tablets, capsules, dragees and zebrafish. retroviral diseases; HIV; bioavailability; Toxicity; Injection; Infusion; Solubilising agents; tablets; capsules; Dragee; suppositories; ambazone} |
| priorityDate | 1989-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 69.